“…At 3 observed time points (3,6, and 12 months) there was a significant difference in repigmentation (PϽ.001, P=.002, and P=.002, respectively) between actively treated lesions and placebo-treated lesions (Figures 2, 3, 4, 5, 6, and 7). At 3,6, and 12 months the the median percentages of the repigmented areas at the actively treated site in group 1 were 84%, 88%, and 93%, respectively (means, 60%, 62%, and 71%), and repigmentation in 70% or more of the treated aeras occurred in 55%, 57%, and 77% of actively treated lesions at the same time points.…”